Literature DB >> 16091861

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia.

Markus J Schwarz1, Holger Krönig, Michael Riedel, Sandra Dehning, Anette Douhet, Ilja Spellmann, Manfred Ackenheil, Hans-Jürgen Möller, Norbert Müller.   

Abstract

An immune process, characterized by a relative predominance of the T helper-2 (Th2) system and possibly induced by a viral infection,may be involved in the pathophysiology of schizophrenia. In this context, functional polymorphisms in the Interleukin-2 (IL-2) and Interleukin-4 (IL-4) genes appear to be principal candidates for genetic schizophrenia research. Further evidence for these candidate genes comes from several linkage analyses, pointing to susceptibility gene loci on chromosomes 4q and 5q, where the genes coding for IL- 2 and IL-4 are located. We carried out a case-control study including 230 schizophrenic patients and 251 healthy persons, investigating the IL-2 -330 T/G single nucleotide polymorphism (SNP) and the IL-4 -590 C/T SNP. A significant association of the IL-2 -330 TT genotype and of the IL-4 -590 CC genotype with schizophrenia could be identified. Our findings may partly account for the relative predominance of the Th2 system in schizophrenia, although they cannot directly explain this immunological imbalance, but may be related to an altered antiviral immune response in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091861     DOI: 10.1007/s00406-005-0603-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  44 in total

1.  Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample.

Authors:  B J Mowry; K R Ewen; D J Nancarrow; D P Lennon; D A Nertney; H L Jones; M S O'Brien; C E Thornley; M K Walters; R R Crowe; J M Silverman; J Endicott; L Sharpe; N K Hayward; M M Gladis; S J Foote; D F Levinson
Journal:  Am J Med Genet       Date:  2000-12-04

Review 2.  Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?

Authors:  Koen Vandenbroeck; An Goris
Journal:  Trends Pharmacol Sci       Date:  2003-06       Impact factor: 14.819

3.  Antibodies to infectious agents in individuals with recent onset schizophrenia.

Authors:  F Markus Leweke; Christoph W Gerth; Dagmar Koethe; Joachim Klosterkötter; Inna Ruslanova; Bogdana Krivogorsky; E Fuller Torrey; Robert H Yolken
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-02       Impact factor: 5.270

4.  Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment.

Authors:  V Arolt; M Rothermundt; K P Wandinger; H Kirchner
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

5.  Chromosome 4 Workshop Summary: Sixth World Congress on Psychiatric Genetics, Bonn, Germany, October 6-10, 1998.

Authors:  J L Kennedy; V S Basile; F M Macciardi
Journal:  Am J Med Genet       Date:  1999-06-18

6.  IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction.

Authors:  N Buchs; T Silvestri; F S di Giovine; M Chabaud; E Vannier; G W Duff; P Miossec
Journal:  Rheumatology (Oxford)       Date:  2000-10       Impact factor: 7.580

7.  Childhood infections, the developing immune system, and the origins of asthma.

Authors:  Peter J M Openshaw; Yuko Yamaguchi; John S Tregoning
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

8.  Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production.

Authors:  R Ganguli; J S Brar; W Solomon; K N Chengappa; B S Rabin
Journal:  Psychiatry Res       Date:  1992-11       Impact factor: 3.222

9.  Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms.

Authors:  R Ganguli; J S Brar; K R Chengappa; M DeLeo; Z W Yang; G Shurin; B S Rabin
Journal:  Arch Gen Psychiatry       Date:  1995-08

10.  Neuron-glia interactions clarify genetic-environmental links in mental illness.

Authors:  Akira Sawa; Mikhail V Pletnikov; Atsushi Kamiya
Journal:  Trends Neurosci       Date:  2004-06       Impact factor: 13.837

View more
  20 in total

1.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

Review 2.  Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

Authors:  Anna M Fineberg; Lauren M Ellman
Journal:  Biol Psychiatry       Date:  2013-02-12       Impact factor: 13.382

Review 3.  [Immunology in schizophrenic disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

Review 4.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

5.  Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.

Authors:  Kinga Szymona; Barbara Zdzisińska; Hanna Karakuła-Juchnowicz; Tomasz Kocki; Martyna Kandefer-Szerszeń; Marta Flis; Wojciech Rosa; Ewa M Urbańska
Journal:  Neurotox Res       Date:  2017-03-08       Impact factor: 3.911

6.  A genome-wide association study of emotion dysregulation: Evidence for interleukin 2 receptor alpha.

Authors:  Abigail Powers; Lynn Almli; Alicia Smith; Adriana Lori; Jen Leveille; Kerry J Ressler; Tanja Jovanovic; Bekh Bradley
Journal:  J Psychiatr Res       Date:  2016-09-09       Impact factor: 4.791

7.  Association between Interleukin 31 Receptor A Gene Polymorphism and Schizophrenia in Korean Population.

Authors:  Ju Yeon Ban; Su Kang Kim; Hak-Jae Kim; Joo-Ho Chung; Tae Kim; Jin Kyung Park; Hyun-Kyung Park; Jong Woo Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

8.  Schizophrenia gene networks and pathways and their applications for novel candidate gene selection.

Authors:  Jingchun Sun; Peilin Jia; Ayman H Fanous; Edwin van den Oord; Xiangning Chen; Brien P Riley; Richard L Amdur; Kenneth S Kendler; Zhongming Zhao
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population.

Authors:  Yuichiro Watanabe; Ayako Nunokawa; Masako Shibuya; Naoshi Kaneko; Hiroyuki Nawa; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

10.  Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.

Authors:  Kwang H Choi; Brandon W Higgs; Serge Weis; Jonathan Song; Ida C Llenos; Jeannette R Dulay; Robert H Yolken; Maree J Webster
Journal:  BMC Psychiatry       Date:  2009-09-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.